Safety and Effectiveness of Synchronized Monopolar Radiofrequency and HIFES in Patients Injected With Botulinum Toxin.

IF 1.5 4区医学 Q3 DERMATOLOGY Journal of Drugs in Dermatology Pub Date : 2024-11-01 DOI:10.36849/JDD.7938

Suneel Chilukuri

{"title":"Safety and Effectiveness of Synchronized Monopolar Radiofrequency and HIFES in Patients Injected With Botulinum Toxin.","authors":"Suneel Chilukuri","doi":"10.36849/JDD.7938","DOIUrl":null,"url":null,"abstract":"Background: Botulinum toxin (BT) has become one of the most frequently sought aesthetic procedures for wrinkle reduction.Objective: This study investigated the effectiveness and safety of a novel device using radiofrequency (RF) and high-intensity facial muscle stimulation (HIFES) in patients injected with BT.Methods: Twelve patients were divided into an Active (N=10) and a Control group (N=2), where the Active received four treatments and the Control none. The facial expressions documented by digital photographs (neutral) and videos (frown, smile, surprise expressions) were taken at all visits (baseline, after last Tx, 1 and 3-month follow-ups) and were evaluated using the Global Aesthetic Improvement Scale (GAIS) and 3D automated analysis. The subject's therapy comfort and satisfaction were assessed.Results: The Active group reported high satisfaction with treatment comfort (6.3±0.2 points on the 7-point Likert scale). 3D analysis showed reduced wrinkle severity (37.4%) and volume increase (+1.5 mL) on the cheeks at 3 months. GAIS evaluation demonstrated the most prominent improvement in smiling facial expression by 2.2±0.1 points. No adverse events were observed.Conclusion: The study results suggest that the combination of HIFES and synchronized RF is a safe and effective treatment for improving facial appearance and muscle tone in patients injected with BT. J Drugs Dermatol. 2024;23(11):937-942.  doi:10.36849/JDD.7938.","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"23 11","pages":"937-942"},"PeriodicalIF":1.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.7938","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Botulinum toxin (BT) has become one of the most frequently sought aesthetic procedures for wrinkle reduction.

Objective: This study investigated the effectiveness and safety of a novel device using radiofrequency (RF) and high-intensity facial muscle stimulation (HIFES) in patients injected with BT.

Methods: Twelve patients were divided into an Active (N=10) and a Control group (N=2), where the Active received four treatments and the Control none. The facial expressions documented by digital photographs (neutral) and videos (frown, smile, surprise expressions) were taken at all visits (baseline, after last Tx, 1 and 3-month follow-ups) and were evaluated using the Global Aesthetic Improvement Scale (GAIS) and 3D automated analysis. The subject's therapy comfort and satisfaction were assessed.

Results: The Active group reported high satisfaction with treatment comfort (6.3±0.2 points on the 7-point Likert scale). 3D analysis showed reduced wrinkle severity (37.4%) and volume increase (+1.5 mL) on the cheeks at 3 months. GAIS evaluation demonstrated the most prominent improvement in smiling facial expression by 2.2±0.1 points. No adverse events were observed.

Conclusion: The study results suggest that the combination of HIFES and synchronized RF is a safe and effective treatment for improving facial appearance and muscle tone in patients injected with BT. J Drugs Dermatol. 2024;23(11):937-942. doi:10.36849/JDD.7938.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

注射肉毒杆菌毒素患者使用同步单极射频和 HIFES 的安全性和有效性。

背景：肉毒杆菌毒素（BT肉毒杆菌毒素（BT）已成为最常见的除皱美容方法之一：本研究调查了一种使用射频（RF）和高强度面部肌肉刺激（HIFES）的新型设备对注射肉毒杆菌毒素患者的有效性和安全性：将 12 名患者分为主动组（10 人）和对照组（2 人），主动组接受四次治疗，对照组不接受治疗。在所有就诊时间（基线、最后一次治疗后、1 个月和 3 个月的随访）拍摄数码照片（中性）和视频（皱眉、微笑、惊讶表情）记录面部表情，并使用全球美学改善量表（GAIS）和三维自动分析进行评估。此外，还对受试者的治疗舒适度和满意度进行了评估：结果：积极组对治疗舒适度的满意度很高（在 7 点李克特量表上得 6.3±0.2分）。三维分析显示，3 个月后，脸颊的皱纹严重程度降低了 37.4%，容积增加了 +1.5 mL。GAIS评估显示，微笑面部表情的改善最为显著，提高了2.2±0.1分。研究未发现任何不良反应：研究结果表明，联合使用 HIFES 和同步射频是一种安全有效的治疗方法，可改善注射 BT 患者的面部外观和肌肉张力。J Drugs Dermatol.2024;23(11):937-942. doi:10.36849/JDD.7938.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Drugs in Dermatology DERMATOLOGY-

CiteScore

2.20

自引率

13.30%

发文量

289

审稿时长

3-6 weeks

期刊介绍： The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.